Researcher.Life Logo

Blood Science : Impact Factor & More

eISSN: 2543-6368pISSN: 2543-6368
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Blood Science

Blood Science Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Quarterly
Publication Time10
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorChinese Association for Blood Sciences
FrequencyQuarterly
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 10
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Blood Science ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Blood Science

T Cell exhaustion: a signal written in heme
  • 14 Apr 2026
  • Blood Science
Orelabrutinib with anti-CD20 monoclonal antibodies is highly effective and well-tolerated as first-line therapy for marginal zone lymphoma
  • 13 Apr 2026
  • Blood Science
ITP, easy as EBV: a rare case of severe immune thrombocytopenic purpura secondary to Epstein-Barr virus
  • 24 Mar 2026
  • Blood Science
Zanubrutinib enhances CD19 CAR T killing of B-cell lymphoma by inhibiting BTK phosphorylation, regulating PI3K/AKT/mTOR pathway, and promoting autophagy
  • 12 Mar 2026
  • Blood Science
Application of next-generation sequencing in the treatment of myelodysplastic syndrome: from mechanisms to clinical practice
  • 10 Mar 2026
  • Blood Science
Identification of two novel TP53 mutations in secondary acute myeloid leukemia following multiple myeloma: a case report
  • 9 Mar 2026
  • Blood Science
T Cell exhaustion: a signal written in heme
  • 14 Apr 2026
  • Blood Science
Orelabrutinib with anti-CD20 monoclonal antibodies is highly effective and well-tolerated as first-line therapy for marginal zone lymphoma
  • 13 Apr 2026
  • Blood Science
ITP, easy as EBV: a rare case of severe immune thrombocytopenic purpura secondary to Epstein-Barr virus
  • 24 Mar 2026
  • Blood Science
Zanubrutinib enhances CD19 CAR T killing of B-cell lymphoma by inhibiting BTK phosphorylation, regulating PI3K/AKT/mTOR pathway, and promoting autophagy
  • 12 Mar 2026
  • Blood Science
Application of next-generation sequencing in the treatment of myelodysplastic syndrome: from mechanisms to clinical practice
  • 10 Mar 2026
  • Blood Science
Identification of two novel TP53 mutations in secondary acute myeloid leukemia following multiple myeloma: a case report
  • 9 Mar 2026
  • Blood Science

FAQs on Blood Science